Eli Lilly and Co banner

Eli Lilly and Co
BMV:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
BMV:LLY
Watchlist
Price: 17 619.97 MXN 1.31% Market Closed
Market Cap: Mex$869.3B

Relative Value

The Relative Value of one LLY stock under the Base Case scenario is hidden MXN. Compared to the current market price of 17 619.97 MXN, Eli Lilly and Co is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LLY Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

LLY Competitors Multiples
Eli Lilly and Co Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Eli Lilly and Co
BMV:LLY
879B MXN 13.5 42.6 28.7 30.7
US
Johnson & Johnson
NYSE:JNJ
573.4B USD 6.1 21.4 14.9 18.3
CH
Roche Holding AG
SIX:ROG
257.8B CHF 4.2 20 11.8 13.3
CH
Novartis AG
SIX:NOVN
231.8B CHF 5.3 21.3 13.2 16.9
UK
AstraZeneca PLC
LSE:AZN
222.8B GBP 5.1 29.3 16.3 22.9
US
Merck & Co Inc
NYSE:MRK
286.7B USD 4.4 15.7 9.7 11.9
IE
Endo International PLC
LSE:0Y5F
240.1B USD 103.6 -82.1 380.1 953.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.5 10.6 7.8 9.2
US
Pfizer Inc
NYSE:PFE
156.1B USD 2.5 20.1 7.7 10.3
US
Bristol-Myers Squibb Co
NYSE:BMY
120.2B USD 2.5 17.1 7.2 8.8
UK
GSK plc
XETRA:GS71
94.9B EUR 2.5 14.3 7.9 9.9
P/E Multiple
Earnings Growth PEG
US
Eli Lilly and Co
BMV:LLY
Average P/E: 21.2
42.6
32%
1.3
US
Johnson & Johnson
NYSE:JNJ
21.4
7%
3.1
CH
Roche Holding AG
SIX:ROG
20
14%
1.4
CH
Novartis AG
SIX:NOVN
21.3
14%
1.5
UK
AstraZeneca PLC
LSE:AZN
29.3
26%
1.1
US
Merck & Co Inc
NYSE:MRK
15.7
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -82.1 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.6
1%
10.6
US
Pfizer Inc
NYSE:PFE
20.1
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
17.1
16%
1.1
UK
GSK plc
XETRA:GS71
14.3
14%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Eli Lilly and Co
BMV:LLY
Average EV/EBITDA: 45.9
28.7
22%
1.3
US
Johnson & Johnson
NYSE:JNJ
14.9
2%
7.4
CH
Roche Holding AG
SIX:ROG
11.8
6%
2
CH
Novartis AG
SIX:NOVN
13.2
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
16.3
13%
1.3
US
Merck & Co Inc
NYSE:MRK
9.7
3%
3.2
IE
E
Endo International PLC
LSE:0Y5F
380.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
7.8
1%
7.8
US
Pfizer Inc
NYSE:PFE
7.7
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.2
-10%
N/A
UK
GSK plc
XETRA:GS71
7.9
3%
2.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Eli Lilly and Co
BMV:LLY
Average EV/EBIT: 100.5
30.7
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
18.3
7%
2.6
CH
Roche Holding AG
SIX:ROG
13.3
5%
2.7
CH
Novartis AG
SIX:NOVN
16.9
9%
1.9
UK
AstraZeneca PLC
LSE:AZN
22.9
21%
1.1
US
Merck & Co Inc
NYSE:MRK
11.9
6%
2
IE
E
Endo International PLC
LSE:0Y5F
953.2
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.2
3%
3.1
US
Pfizer Inc
NYSE:PFE
10.3
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
8.8
-7%
N/A
UK
GSK plc
XETRA:GS71
9.9
6%
1.6
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett